New Insight to Overcome Tumor Resistance: An Overview from Cellular to Clinical Therapies

Disease relapse caused by drug resistance still represents a major clinical hurdle in cancer treatments. Tumor cells may take advantage of different intracellular and genetic systems attenuating the drug effects. Resistant cells or minimal residual disease (MRD) cells have strong clinical relevance,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Giulia Mitola, Paolo Falvo, Francesco Bertolini
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/d75c0a279a704ce8824a27bc2c754cda
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!